News

AddToAny

Google+ Facebook Twitter Twitter

AI can predict Crohn’s disease recurring after surgery

Using an artificial intelligence (AI) tool that emulates how humans visualise and is trained to recognise and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn’s disease with high accuracy by evaluating histological images.

The AI tool also revealed previously unrecognised differences in adipose cells and significant differences in the extent of mast cell infiltration in the subserosa, or outer lining of the intestine, comparing patients with and without disease recurrence.

The 10-year rate of postoperative symptomatic recurrence of Crohn’s disease, a chronic inflammatory gastrointestinal disease, is estimated at 40%.

There are scoring systems to evaluate Crohn’s disease activity and the existence of postoperative recurrence, but no system had been developed to predict whether Crohn’s disease might recur.

Lead author Takahiro Matsui said: “Most of the analysis of histopathological images using AI in the past have targeted malignant tumours. We aimed to obtain clinically useful information for a wider variety of diseases by analysing histopathology images using AI. We focused on Crohn’s disease, in which postoperative recurrence is a clinical problem.”

Sixty-eight patients with Crohn’s disease who underwent bowel resection were included in the study.

bit.ly/3yxyRfN

 

Image credit | Shutterstock

Related Articles

Robotic hand with handgun aiming in wrong direction. Fatal AI error - Image credit - Shutterstock-2309476357

Tissue contamination distracts AI

In a new study, scientists trained three AI models to scan microscope slides of placenta tissue to detect blood vessel damage, estimate gestational age and classify macroscopic lesions.

Digital pathology cleared for use-history digital pathology-CREDIT-university of warwick

Digital pathology cleared for use

New research has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.

Breast cancer 3D tomography-CREDIT-Science-Photo-Library-c0303374

Two decades of hHER2 testing

This year marks the 20th anniversary of Her2 breast cancer testing at the Royal Cornwall Hospital. Senior Biomedical Scientist Mary Jones looks back over the past two decades.

A molecular biologist working with a microscope in a modern scientific Laboratory, we see a computer screen in the foreground- CREDIT - istock-1390303303

Precision pathology for cancer with new ai tool

A new AI tool interprets medical images with unprecedented clarity, according to the results of a new study.

Top